(Q43907205)

English

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.

scientific article published on 27 February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

12

object named as

Sharon Nachman

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Paul Krogstad

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Sophia Lee

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

George Johnson

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Kenneth Stanley

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

James McNamara

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Rosaura Aguayo

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Arry Dieudonne

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Margaret Khoury

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Hermann Mendez

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Andrew Wiznia

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Pediatric AIDS Clinical Trials Group 377 Study Team

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

0 references

publication date

27 February 2002

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Clinical Infectious Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

34

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

991-1001

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11880966%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children wi

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

A pilot study of combination therapy with indinavir, stavudine (d4T), and didanosine (ddI) in children infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Inhibition of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

A randomized study of combined zidovudine-lamivudine versus didanosine monotherapy in children with symptomatic therapy-naive HIV-1 infection

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

1 reference

https://api.crossref.org/works/10.1086%2F338814

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43907205&oldid=2104313057"